ADAT3: A Potential Drug Target for Various Diseases (G113179)

Target Name: ADAT3

NCBI ID: G113179

ADAT3

ADAT3: A Potential Drug Target for Various Diseases

ADAT3 (ADAT3_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the ADAM (Amino Acid Repeat and Modification) family, which includes proteins that are involved in various cellular processes, including cell signaling and tissue repair.

ADAT3 has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these conditions is not well understood, but it is thought to play a key role in the development and progression of these diseases.

One of the reasons why ADAT3 is a promising drug target is its role in the development of cancer. Many studies have shown that ADAT3 is highly expressed in various types of cancer, including breast, ovarian, and prostate cancer. It is also involved in the regulation of cell growth and survival, which are key factors in the development of cancer.

In addition to its role in cancer, ADAT3 is also thought to be involved in the development and progression of neurodegenerative diseases. Many of these diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles. ADAT3 is thought to be involved in the production and maintenance of these tangles, which can lead to the destruction of nerve cells and the progression of the disease.

Another potential application of ADAT3 as a drug target is its role in the treatment of autoimmune disorders. Many of these disorders, such as rheumatoid arthritis and lupus, involve an overactive immune system that leads to inflammation and damage to body tissues. ADAT3 is thought to be involved in the regulation of immune cell function, and may be a useful target for the development of new treatments for these disorders.

In conclusion, ADAT3 is a protein that is expressed in various tissues of the human body and is thought to play a key role in the development and progression of a variety of diseases. Its potential as a drug target or biomarker makes it an attractive target for research into new treatments for these conditions. Further studies are needed to fully understand its role in these diseases and to develop effective treatments.

Protein Name: Adenosine Deaminase TRNA Specific 3

The "ADAT3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADAT3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets